Cumberland Pharmaceuticals Inc
CPIX· Nasdaq
CPIXCumberland Pharmaceuticals Inc
Filed Aug 9, 2012 · 10-Q · 40 days after period end · 0001193125-12-347942
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $12.37M | $14.39M | $10.74M |
| Net Income | $1.74M | $2.18M | $287.30K |
| EPS Diluted | $0.09 | $0.11 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 9, 2012 · 40 d after period end
